| 摘要 |
<p>Compounds of the invention, useful as thrombin inhibitors and having therapeutic value in for example, preventing coronary artery disease, have structure: (I) or a pharmaceutically acceptable salt thereof, wherein A is (a), (b), (c), (d), or (e).</p> |
